Jaka jest cena za Stemcell Holdings, Inc. (STMM)

Cena za Stemcell Holdings, Inc. (STMM) wynosi $0.06

Jaka jest kapitalizacja rynkowa dla Stemcell Holdings, Inc. (STMM)

Kapitalizacja rynkowa dla Stemcell Holdings, Inc. (STMM) wynosi $1.64M

Stemcell Holdings, Inc. (STMM) Stopa Dywidendy

Stemcell Holdings, Inc., primarily operating through its subsidiary Stemcell Co., Ltd., specializes in the regenerative medicine sector. The company provides crucial technical support for the cultivation, storage, and delivery of stem cells, alongside administrative and consulting services for clinics. It offers two distinct stem cell regenerative therapies: autologous mesenchymal stem cells derived from adipose tissue and natural killer cells. To facilitate its stem cell culturing activities, Stemcell Holdings coordinates patient introductions to clinics, manages scheduling, and provides translation services to overcome language barriers between patients and medical professionals. Additionally, the firm offers internet marketing solutions, specifically search engine optimization for clinics, and engages in property and equipment rental. Founded in Tokyo, Japan, in 2015, the company was formerly known as Perfect Acquisition, Inc. before changing its name to Stemcell Holdings, Inc. in January 2016. As of May 2, 2016, Stemcell Holdings, Inc. operates as a subsidiary of Primavera Singa Pte Ltd.

Rok	Stopa dywidendy	Zmień
Za mało danych dla podanych dat.

Rok

Stopa dywidendy

Zmień

Za mało danych dla podanych dat.

Firma	Stopa dywidendy	Kraj
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
Lonza Group AG LONN.SW	0.00%	CH
Samsung Biologics Co.,Ltd. 207940.KS	0.00%	KR
UCB S.A. UCB.BR	0.48%	BE

Firma

Stopa dywidendy

Kraj